Latest Production News

Firebird Metals has secured two key patents for its proprietary Lithium Manganese Iron Phosphate (LMFP) battery materials, reinforcing its position in the emerging $20 billion LMFP market. The company’s integrated production approach and expanding IP portfolio set the stage for global growth amid shifting technology controls.

Ausgold Limited’s Definitive Feasibility Study for the Katanning Gold Project confirms a decade of strong gold production and robust financial returns, while regional exploration efforts continue to expand the growth pipeline.

Peregrine Gold Limited has announced a major discovery of a high-grade Channel Iron Deposit spanning over 7.7km near key BHP iron ore operations in Western Australia. Initial assays reveal iron grades averaging 57%, highlighting significant potential for the Newman Gold Project.

Koonenberry Gold Limited reports compelling gold intersections at its Enmore Project, underpinning plans for an extensive follow-up drilling campaign backed by a $5 million capital raise.

Arizona Lithium has secured $900,000 through an at-the-market equity raise to fund the construction of its first production facility at the Prairie Lithium Project in Canada.

Yowie Group has arranged a $1 million short-term funding facility from parent Keybridge Capital to manage cash flow while investigating former directors' use of funds and intra-group loans.

Connexion Mobility reported steady revenue growth and a 7% increase in net profit before tax for Q4 FY25, driven by expanding SaaS subscriptions and strategic product enhancements.

Orbminco Limited has executed a binding agreement to acquire the Majestic North Gold Project in Western Australia and commenced maiden drilling, marking a significant step in its growth strategy.

Mineral Commodities Ltd updates investors on the postponed completion of its Skaland Graphite Project sale due to the buyer's funding constraints, with new non-refundable payments and operational support commitments outlined.

MRG Metals Limited has announced a non-renounceable pro-rata entitlement offer to raise approximately $818,000, aiming to fund exploration and development activities across its heavy mineral sands projects in Mozambique.

TAL Dai-ichi Life Australia has obtained all necessary regulatory approvals, including from APRA, to finalize its minority investment in Challenger Limited, acquiring a 19.9% equity stake.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.